Abstract 1 The addition of furazolidone to the feed at the therapeutic level (0.04% w/w, 10
days) inhibited monoamine oxidase (MAO) activity by 47 to 72% in chicken duodenal …

In the chicken, monoamine oxidase (MAO) activity in the brain, heart and alimentary tract
was inhibited when furazolidone was given at the therapeutic dose (0· 04%, w/w, in the feed …

Primary cultures of pig hepatocytes were used to examine the irreversible inhibition of
monoamine oxidase (MAO), which has been observed in tissues of a number of different …

Furazolidone (N-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidinone) in saturated solution in
vitro did not affect rat liver monoamine oxidase (MAO). After a single oral dose in rats …

Furazolidone (FZ), a potent inhibitor of monoamine oxidase (MAO), fed at concentrations of
700 ppm to turkey poults 2 through 5 weeks of age, produces cardiomyopathy and …

The pharmacological and toxicological properties of furazolidone have been briefly
reviewed. Among the most important pharmacological actions of furazolidone is the …

In rats, the effects of the antiseptics furazolidone, nitrofurantoine, and nitrofurazone on the
activity of monoamine oxidase (MAO) were studied. 24 hours after oral application of …

One-day-old chicks were raised to maturity on a diet fortified with 0.0055% furazolidone.
Analyses of tissue extracts by a liquid chromatographic-electrochemlcal detection screening …

Furazolidone (0· 04% w/w in the feed, 10 days) reduced the feed intake and growth in 9
week old chickens, and increased the amount of 5‐hydroxytryptamine (5‐HT) in the brain …

Furazolidone (Furoxone) was found to be a potent inhibitor of monoamine oxidase (MAO) in
man. It produced marked supersensitivity to tyramine and amphetamine, inhibition of …